By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 114.15 |
Change Today | $ -0.62 |
% Change | -0.54 % |
52 Week High | $121.40 |
52 Week Low | $76.72 |
Volume | 3,812,336 |
Shares Issued | 1,246.00m |
Market Cap | $142,231m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 11 |
Neutral | 6 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
16:00 | 572,618 @ $114.15 |
15:59 | 122 @ $114.14 |
15:59 | 100 @ $114.14 |
15:59 | 200 @ $114.15 |
15:59 | 974 @ $114.16 |
You are here: research